Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)
Clinical trial NCT00632827 · TERMINATED
Trial details
- NCT number
- NCT00632827
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2014-06-23
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.